Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis.
Charles DolladilleJulia AkrounPierre-Marie MoriceAnne DompmartinEmilien EzineMarion SassierAngélique Da-SilvaAnne-Flore PlaneDamien LegalloisJean-Mathieu L'OrphelinJoachim AlexandrePublished in: European heart journal (2021)
In RCTs, ICI use was associated with six CV irAEs, not confined to myocarditis and pericarditis.